My experience made me wonder what proactive steps people with diabetes can take when they have to come off a GLP-1 drug even temporarily because of cost, side effects , or other reasons
A team of researchers at Stanford Medicine conducted the study, published last week in the journal Nature
Divide total milligrams by total volume to get mg/mL
The high cost The cost is one of the biggest barriers to long-term use
Even at low doses, these medications carry risks including pancreatitis (requiring discontinuation if suspected), gallbladder disease, and rare but serious adverse events such as medullary thyroid carcinoma (boxed warning
Although Novo Nordisk will undoubtedly face price competition regardless as Lilly rolls out its orforglipron launch, the question is to what degree this will happen